CYTEK BIOSCIENCES INC
CTKBNASDAQTrading Snapshot
- Day Range
- $388.17 β $396.80
- 52-Week Range
- $3.28 β $6.18
- Volume
- $1.81B
- Avg Volume
- $2.39B
- Shares Outstanding
- 129.1M
- Next Earnings
- Dec 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $201M
- Last Q Revenue
- $48M
- P/E Ratio
- β
- P/S Ratio
- 3.6x
- EPS (TTM)
- $-0.63
- Dividend Yield
- β
- Dilution (1yr)
- β0.8%
Why Investors Own CTKB
- βHigh-growth profile β revenue up +29.6% YoY with expanding US Equity exposure.
- βHealthy economics β 35% gross margin and 28% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CYTEK BIOSCIENCES INC
CTKBAbout CYTEK BIOSCIENCES INC
Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
CYTEK BIOSCIENCES INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift CTKB price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CYTEK BIOSCIENCES INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.